SCHEMBL20766563

SCHEMBL20766563

CC(C)COc1ccc(COC(=O)N(Cc2ccc(F)cc2)[C@H]2CCNC[C@H]2CF)cc1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766535 1.00 HTR2A (0.81) HTR2A
SCHEMBL20766562 0.92 HTR2A (0.81) HTR2A
SCHEMBL20766817 0.92 HTR2A (0.81) HTR2A
SCHEMBL20766820 0.91 HTR2A (0.80) HTR2A
SCHEMBL20767069 0.90 HTR2A (0.80) HTR2A
SCHEMBL23312340 0.90 HTR2A (1.00) HTR2A
SCHEMBL20767317 0.90 HTR2A (1.00) HTR2A
SCHEMBL20765992 0.88 HTR2A (0.64) HTR2A
SCHEMBL20765982 0.88 HTR2A (0.64) HTR2A
SCHEMBL20765955 0.86 HTR2A (0.63) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672960-A2 COMPOUNDS, SALTS THEREOF AND THEIR USE FOR THE TREATMENT OF DISEASES Acadia Pharmaceuticals Inc. (US) 2020-07-01 EP claimed
WO-2019040104-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO claimed